Dysregulated expression of MIC-1/PDF in human prostate tumor cells.

[1]  S. J. Higgins,et al.  The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.

[2]  R. Gittes.  Carcinoma of the prostate. , 1991, The New England journal of medicine.

[3]  S. Batra,et al.  Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: integration, expression and ultrastructural changes. , 1991, Journal of cell science.

[4]  Chawnshang Chang,et al.  The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells , 1995, Molecular and Cellular Endocrinology.

[5]  Mike Wilson,et al.  Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  E. Barrack.  TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicity , 1997 .

[7]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Vukicevic,et al.  Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family* , 1998, The Journal of Biological Chemistry.

[9]  A. Schönthal,et al.  Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.

[10]  W. D. Fairlie,et al.  MIC‐1 is a novel TGF‐β superfamily cytokine associated with macrophage activation , 1999, Journal of leukocyte biology.

[11]  N. Bruchovsky,et al.  Prostate cancer: molecular biology of early progression to androgen independence. , 1999, Endocrine-related cancer.

[12]  The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. , 2000 .

[13]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[14]  Y. Labrie,et al.  Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells , 2001, Molecular and Cellular Endocrinology.

[15]  R. Vessella,et al.  Placental bone morphogenetic protein (PLAB) gene expression in normal, pre‐malignant and malignant human prostate: Relation to tumor development and progression , 2001, International journal of cancer.

[16]  B. Dave,et al.  Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  D. Tindall,et al.  Androgen receptor signaling in androgen-refractory prostate cancer. , 2001, Journal of the National Cancer Institute.

[18]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[19]  E. Keller,et al.  Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  W. D. Fairlie,et al.  Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study , 2002, The Lancet.

[21]  S. Batra,et al.  Establishment and characterization of androgen‐independent human prostate cancer LNCaP cell model , 2002, The Prostate.

[22]  Angie Rizzino,et al.  Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. , 2002, Carcinogenesis.

[23]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[24]  H. Klocker,et al.  Androgen receptors in prostate cancer. , 2002, The Journal of urology.

[25]  S. Batra,et al.  Current status of the molecular genetics of human prostatic adenocarcinomas , 2003, International journal of cancer.

[26]  J. Welsh,et al.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum , 2003, Proceedings of the National Academy of Sciences of the United States of America.